Goldman Sachs’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.74M Buy
811,560
+71,460
+10% +$740K ﹤0.01% 3415
2025
Q4
$9.15M Buy
740,100
+119,123
+19% +$1.28M ﹤0.01% 3177
2025
Q3
$5.48M Buy
620,977
+41,585
+7% +$323K ﹤0.01% 3554
2025
Q2
$3.7M Sell
579,392
-511,263
-47% -$2.93M ﹤0.01% 3699
2025
Q1
$5.3M Buy
1,090,655
+121,583
+13% +$1.01M ﹤0.01% 3289
2024
Q4
$9.26M Buy
969,072
+521,224
+116% +$4.78M ﹤0.01% 2874
2024
Q3
$3.74M Sell
447,848
-163,121
-27% -$1.48M ﹤0.01% 3618
2024
Q2
$4.17M Buy
610,969
+318,016
+109% +$1.37M ﹤0.01% 3329
2024
Q1
$741K Sell
292,953
-458,934
-61% -$1.03M ﹤0.01% 4528
2023
Q4
$1.8M Buy
751,887
+93,301
+14% +$219K ﹤0.01% 4007
2023
Q3
$2.24M Sell
658,586
-11,864
-2% -$65.8K ﹤0.01% 3682
2023
Q2
$4.93M Sell
670,450
-230,095
-26% -$2.13M ﹤0.01% 3121
2023
Q1
$9.33M Buy
900,545
+120,900
+16% +$1.46M ﹤0.01% 2485
2022
Q4
$9.21M Buy
779,645
+320,923
+70% +$4.97M ﹤0.01% 2658
2022
Q3
$9.63M Buy
458,722
+387
+0.1% +$10.8K ﹤0.01% 2545
2022
Q2
$14.2M Buy
458,335
+109,018
+31% +$3.72M ﹤0.01% 2180
2022
Q1
$14.3M Buy
349,317
+33,632
+11% +$1.48M ﹤0.01% 2339
2021
Q4
$13.7M Sell
315,685
-391,936
-55% -$17.7M ﹤0.01% 2473
2021
Q3
$35.4M Buy
707,621
+52,521
+8% +$3.18M 0.01% 1560
2021
Q2
$41.3M Buy
655,100
+176,729
+37% +$11.4M 0.01% 1428
2021
Q1
$44.4M Sell
478,371
-422,244
-47% -$43.2M 0.01% 1261
2020
Q4
$80.7M Buy
900,615
+257,334
+40% +$23.6M 0.03% 753
2020
Q3
$66.5M Sell
643,281
-119,943
-16% -$12.9M 0.02% 801
2020
Q2
$60.4M Sell
763,224
-202,716
-21% -$15.1M 0.02% 823
2020
Q1
$55.9M Sell
965,940
-159,043
-14% -$9.17M 0.02% 794
2019
Q4
$60.7M Buy
1,124,983
+161,148
+17% +$8.74M 0.02% 1005
2019
Q3
$50.4M Buy
963,835
+83,211
+9% +$3.88M 0.02% 1104
2019
Q2
$42.5M Buy
880,624
+337,422
+62% +$16.2M 0.01% 1252
2019
Q1
$27.4M Sell
543,202
-253,171
-32% -$14.9M 0.01% 1597
2018
Q4
$47.2M Sell
796,373
-233,202
-23% -$15M 0.02% 1133
2018
Q3
$67.8M Sell
1,029,575
-35,568
-3% -$2.08M 0.02% 1011
2018
Q2
$53.8M Buy
1,065,143
+150,140
+16% +$7.82M 0.02% 1162
2018
Q1
$48.2M Buy
915,003
+129,691
+17% +$6.46M 0.01% 1222
2017
Q4
$36.5M Buy
785,312
+577,036
+277% +$24.3M 0.01% 1510
2017
Q3
$8.42M Buy
208,276
+36,848
+21% +$1.33M ﹤0.01% 2709
2017
Q2
$5.81M Buy
171,428
+40,453
+31% +$1.25M ﹤0.01% 2936
2017
Q1
$3.8M Sell
130,975
-423,622
-76% -$12.9M ﹤0.01% 3168
2016
Q4
$18.2M Sell
554,597
-280,851
-34% -$8.42M 0.01% 2027
2016
Q3
$26.3M Buy
835,448
+44,336
+6% +$1.29M 0.01% 1695
2016
Q2
$22.2M Buy
791,112
+566,571
+252% +$22.2M 0.01% 1720
2016
Q1
$8.16M Sell
224,541
-70,408
-24% -$2.49M ﹤0.01% 2375
2015
Q4
$11.8M Buy
294,949
+46,126
+19% +$1.61M ﹤0.01% 2130
2015
Q3
$7.09M Sell
248,823
-119,755
-32% -$3.95M ﹤0.01% 2564
2015
Q2
$12.1M Buy
368,578
+124,472
+51% +$3.86M ﹤0.01% 2183
2015
Q1
$7.02M Sell
244,106
-15,847
-6% -$455K ﹤0.01% 2587
2014
Q4
$7.08M Sell
259,953
-90,253
-26% -$2.15M ﹤0.01% 2656
2014
Q3
$7.46M Buy
350,206
+60,899
+21% +$1.39M ﹤0.01% 2623
2014
Q2
$6.5M Buy
289,307
+12,343
+4% +$287K ﹤0.01% 2751
2014
Q1
$7M Sell
276,964
-21,710
-7% -$548K ﹤0.01% 2684
2013
Q4
$6.87M Buy
298,674
+6,985
+2% +$146K ﹤0.01% 2734
2013
Q3
$5.56M Buy
291,689
+119,495
+69% +$2.13M ﹤0.01% 2812
2013
Q2
$2.48M Buy
+172,194
New +$2.49M ﹤0.01% 3497

Other funds holding EBS